2 completed, 1 not yet recruiting, 1 unknown. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Not yet recruiting 1, Unknown 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Insomnia, Fatal Familial: new trials by email Literature Review of Insomnia, Fatal Familial trials Research Report on Insomnia, Fatal Familial
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of ALN-6457 in Adult Participants With Symptomatic Prion Disease (PrD) ALN-6457 - Prion Disease | Phase 1 / Phase 2 | Not yet recruiting | Regeneron Pharmaceuticals | 60 | 2026-10-23 | 2026-09-22 |
| Knee Arthritis Treatment With Autologous Fragmented Adipose Tissue and PRP - Comparison of Two Treatment Methods autologous adipose tissue transfer, PRP injections - Osteo Arthritis Knee, Knee Osteoarthritis | Phase 2 | Unknown | Rehasport Clinic | 60 | 2018-07-30 | 2020-03-25 |
| Familiar Fatal Insomnia: Preventive Treatment With Doxycycline in Subject With Disease Risk Doxycycline Hcl, Placebo - Familial Fatal Insomnia | Phase 2 | Completed | Mario Negri Institute for Pharmacological Research | 29 | 2011-04-28 | 2024-12-05 |
| CJD (Creutzfeldt-Jakob Disease) Quinacrine Study Quinacrine, Placebo - Creutzfeldt-Jakob Disease | Phase 2 | Completed | University of California, San Francisco | 69 | 2005-04-01 | 2014-06-09 |
Creutzfeldt-Jakob Syndrome (2) · Dementia (2) · Prion Diseases (2) · Arthritis (1) · Central Nervous System Diseases (1) · Central Nervous System Infections (1) · Gerstmann-Straussler-Scheinker Disease (1) · Joint Diseases (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1) · Osteoarthritis, Knee (1) · Proteostasis Deficiencies (1)
Dyssomnias (4) · Infections (4) · Sleep Disorders, Intrinsic (4) · Sleep Initiation and Maintenance Disorders (4) · Sleep Wake Disorders (4) · Central Nervous System Diseases (3) · Central Nervous System Infections (3) · Nervous System Diseases (3) · Neurodegenerative Diseases (3) · Brain Diseases (2) · Mental Disorders (2) · Neurocognitive Disorders (2) · Prion Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1)
Quinacrine (1)
Mario Negri Institute for Pharmacological Research (1) · Regeneron Pharmaceuticals (1) · Rehasport Clinic (1) · University of California, San Francisco (1)
Poland (1) · United States (1)
Bruce L. Miller, MD (1) · Michael Geschwind, MD, PhD (1) · Pawel Bakowski, MD PhD (1) · Tomasz Piontek, MD PhD (1)
P01AG021601 (1)